Nutex Health Inc. — Deep Value Healthcare Delivery And Hospital Management Platform

As part of our ongoing series at The Acquirer’s Multiple, each week we highlight a stock from our Stock Screeners that may be a deeply undervalued opportunity hiding in plain sight.

This week’s spotlight is Nutex Health Inc. (NUTX) — a healthcare delivery and hospital management platform focused on micro-hospitals, specialty care facilities, and population health services across the United States.

Operating at the intersection of healthcare infrastructure and services, Nutex is positioned to benefit from rising demand for localized, flexible acute care delivery models.

Business Overview

Nutex operates a hybrid healthcare model combining:

✓ Micro-hospital ownership and partnerships
✓ Hospital management services
✓ Value-based population health programs
✓ Scalable outpatient and specialty care infrastructure

This decentralized model aims to deliver hospital-level care closer to patients while maintaining cost efficiency compared with traditional large hospital systems.

What Is IV/P (Intrinsic Value to Price)?

IV/P compares a conservative intrinsic valuation to current price:

IV/P > 1 → Undervalued
IV/P < 1 → Overvalued

NUTX’s IV/P = 3.20, indicating the stock may trade at roughly one-third of conservative intrinsic value estimates — suggesting substantial potential upside if operating performance stabilizes and growth continues.

Supporting Metrics

Revenue (TTM): ≈ US$ 981M
Gross Profit: ≈ US$ 540M
Operating Income: ≈ US$ 359M
Net Income: ≈ US$ 121M
Free Cash Flow (TTM): ≈ US$ 176M

Acquirer’s Multiple (AM): 2.82

An AM below 3 places NUTX deep in statistically cheap territory — typically associated with distressed cyclicals or structurally challenged businesses, which may not fully reflect Nutex’s operating growth profile.

Revenue & Profitability

Recent financials show strong profitability momentum:

• Gross margin ≈ 55%

• Operating margin ≈ 36%

• Net margin ≈ 12%

• Diluted EPS (TTM): ≈ $20+ per share

These margins are unusually strong for healthcare facility operators and reflect:

• High acuity service mix

• Partner hospital economics

• Operational leverage from scaling facilities

If sustainable, this profitability profile could materially re-rate valuation multiples.

Balance Sheet Position

From the balance sheet:

Total Assets: ≈ US$ 655M
Total Liabilities: ≈ US$ 467M
Shareholders’ Equity: ≈ US$ 188M
Total Debt: ≈ US$ 341M
Net Debt: ≈ US$ ~300M (approx.)

While leverage exists, it is consistent with healthcare facility expansion financing and supported by strong operating cash flow generation.

Cash Flow & Capital Efficiency

Cash flow is a notable strength:

Operating Cash Flow (TTM): ≈ US$ 178M
Capital Expenditure: ≈ US$ -1.5M
Free Cash Flow: ≈ US$ 176M

Key implications:

✓ High cash conversion from earnings
✓ Minimal maintenance CapEx relative to revenue
✓ Ability to fund expansion internally
✓ Potential for debt reduction or shareholder returns

Healthcare infrastructure businesses with this level of cash generation often command significantly higher multiples.

Why NUTX May Be Undervalued

The valuation discount appears driven by perception gaps.

Market Concerns:

• Small-cap healthcare operator with limited coverage
• Complexity of joint venture hospital structures
• Reimbursement environment uncertainty
• Rapid growth sometimes viewed as higher risk

But fundamentals suggest mispricing:

• AM of 2.82 indicates deep statistical value
• IV/P of 3.20 implies significant intrinsic upside
• Nearly US$ 1B revenue scale achieved
• Strong free cash flow generation
• Expanding decentralized healthcare model tailwinds

Conclusion

With an IV/P of 3.20 and an Acquirer’s Multiple of 2.82, Nutex Health screens as a potentially deeply undervalued healthcare infrastructure and services company.

Its combination of:

• Rapid revenue growth

• Strong operating margins

• High free cash flow conversion

• Exposure to evolving healthcare delivery models

suggests the market may be discounting execution risk more heavily than current financial performance warrants.

For value-oriented investors comfortable with healthcare services volatility, NUTX may represent an asymmetric opportunity where improving fundamentals meet depressed valuation multiples.